Rankings
▼
Calendar
BCYC Q1 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
+127.4% YoY
Gross Profit
$108,000
1.7% margin
Operating Income
-$3M
-51.6% margin
Net Income
-$7M
-101.9% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
+504.0%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$276,000
Balance Sheet
Total Assets
$78M
Total Liabilities
$21M
Stockholders' Equity
$57M
Cash & Equivalents
$59M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$3M
+127.4%
Gross Profit
$108,000
-$901,000
+112.0%
Operating Income
-$3M
-$3M
-14.0%
Net Income
-$7M
-$3M
-156.6%
← FY 2019
All Quarters
Q2 2019 →